These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 5735425)

  • 1. [Clinical and biochemical study of the therapeutic effect of the diuretic triamterene in ascitogenic cirrhosis].
    Păunescu-Podanu A; Demirian H; Ionitã C; Georgescu D; Tarachiu A; Anghel R; Rubingher L
    Med Interna (Bucur); 1968 May; 20(5):523-30. PubMed ID: 5735425
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of triamterene in combination with other diuretics in liver cirrhosis].
    Polli E
    Minerva Med; 1963 Oct; 54(81 Suppl):3018-23. PubMed ID: 5877333
    [No Abstract]   [Full Text] [Related]  

  • 3. [Influence of diuretics on the survival of 180 patients with cirrhosis of the liver and ascites].
    Robert M; Portmann B
    Schweiz Med Wochenschr; 1969 Feb; 99(6):178-82. PubMed ID: 5781367
    [No Abstract]   [Full Text] [Related]  

  • 4. Polythiazide as a diuretic. A clinical trial.
    Kaur J; Wahi PL
    J Indian Med Assoc; 1967 Jan; 48(1):13-7. PubMed ID: 6040102
    [No Abstract]   [Full Text] [Related]  

  • 5. [Diuretic treatment and metabolic alkalosis in ascitic liver cirrhosis].
    Grassi V; Porcellati C; Corea L; Todisco T
    Minerva Nefrol; 1968; 15(4):258-60. PubMed ID: 5745815
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative study of diuretic drugs used in cirrhotic and ascitic patients].
    Lennhoff M; Duhalt R; Peña JC
    Rev Invest Clin; 1968; 20(2):165-80. PubMed ID: 5721631
    [No Abstract]   [Full Text] [Related]  

  • 7. [The behavior of uricemia during treatment with spironolactone and with other diuretics].
    Bufalari A; Meloni G
    Minerva Med; 1967 Nov; 58(89):3815-22. PubMed ID: 6074933
    [No Abstract]   [Full Text] [Related]  

  • 8. [Triamterene in diuretic therapy of cirrhogenic ascites. Modifications of water-saline metabolism induced by its administration alone and in combination with fluprednisolone, methopyrone, mercaptomerine and benzothiazides].
    Ventura E; Loiodice L; Marani L
    Minerva Med; 1963 Oct; 54(81 Suppl):3024-7. PubMed ID: 5877334
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical evaluation of the use of diuretics in the ascitic phase of hepatic cirrhosis].
    Castagnolo B; De Colibus V; Napolitano L; Aliperta A; Caldarelli G; Abignente F
    Clin Ter; 1977 Dec; 83(6):625-9. PubMed ID: 343976
    [No Abstract]   [Full Text] [Related]  

  • 10. [ON MODIFICATIONS OF PLASMA AND URINARY ELECTROLYTES IN ASCITOGENIC HEPATIC CIRRHOSIS IN TREATMENT WITH TRIAMTERENE ALONE AND ASSOCIATED WITH HYDROCHLOROTHIAZIDE AND WITH SPIRONOLACTONE].
    MELLONI GF; BARATTA C; MARANGONI R; MERLO L; ANTOGNETTI R
    Minerva Med; 1964 Sep; 55():2722-37. PubMed ID: 14199461
    [No Abstract]   [Full Text] [Related]  

  • 11. Amiloride (MK-870), a new antikaluretic diuretic. Comparison to other antikaluretic diuretics in patients with liver disease and ascites.
    Yamada S; Reynolds TB
    Gastroenterology; 1970 Dec; 59(6):833-41. PubMed ID: 5486268
    [No Abstract]   [Full Text] [Related]  

  • 12. [INFLUENCE OF TRIAMTERENE ON SALIDIURESIS AND RENAL HEMODYNAMICS OF INDIVIDUALS WITH ASCITOGENIC HEPATIC CIRRHOSIS IN TREATMENT WITH HYDROCHLOROTHIAZIDE].
    CASIROLA G; CHERIE LIGNIERE EL; POZZI E
    Riv Patol Clin; 1963 Dec; 18():837-50. PubMed ID: 14158421
    [No Abstract]   [Full Text] [Related]  

  • 13. [Controlled clinical trial of the association of furosemide and triamterene].
    Azzi E; Perraro F
    Clin Ter; 1971 Mar; 56(6):501-22. PubMed ID: 5131091
    [No Abstract]   [Full Text] [Related]  

  • 14. [Triamterene in the treatment of liver cirrhosis with ascites].
    Rodes J; Bosch J; Arroyo V; Nicolau I; Teres J; Bruguera M
    Rev Clin Esp; 1972 Dec; 127(6):1101-8. PubMed ID: 4663288
    [No Abstract]   [Full Text] [Related]  

  • 15. [Diuretics in cirrhosis. Accidents. Indications].
    Andrieu J; Lesueur G
    Presse Med (1893); 1969 Mar; 77(16):575-8. PubMed ID: 5783378
    [No Abstract]   [Full Text] [Related]  

  • 16. Reversal of the suppressed potassium excretion during treatment with combinations of antikaliuretic drugs (spironolactone, canrenone, triamterene, amiloride) in patients with liver cirrhosis.
    Radó JP; Sawinsky I; Juhos E
    Int J Clin Pharmacol Biopharm; 1976 Oct; 14(3):163-7. PubMed ID: 1002353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spironolactone in diuretic regimens with meralluride or thiazides for pseudointractable ascites of cirrhosis.
    Gold H; Golfinos AJ; Mehta D; Messeloff CR; Zahm W
    J Clin Pharmacol New Drugs; 1972 Jan; 12(1):35-9. PubMed ID: 4480885
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pathogenesis and therapy of ascites in liver cirrhosis].
    Dölle W
    Internist (Berl); 1966 Jan; 7(1):48-54. PubMed ID: 4861685
    [No Abstract]   [Full Text] [Related]  

  • 19. Kinetics and dynamics of triamterene at steady-state in patients with cirrhosis.
    Dao MT; Villeneuve JP
    Clin Invest Med; 1988 Feb; 11(1):6-9. PubMed ID: 3365882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diuretic effect of triamterene in 20 patients with hepatic cirrhosis with ascites].
    Plaza de los Reyes M; Bardi A; Merino I; Domínguez JP; Poblete E; Penna M; Doerr E; Generini G
    Rev Med Chil; 1965 Sep; 93(9):544-8. PubMed ID: 5888084
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.